A Baptist Health patient says she was shocked to find another person’s private medical information in her online health ...
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. Quest beat analysts’ revenue expectations by 1.4% ...
Quest Diagnostics (DGX) stock climbed slightly today, gaining just above 0% after a relatively quiet session. Investors seem to be weighing recent performance, as shares are up 17% year-to-date and ...
In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...
Why Analysts See the Story Changing for Quest Diagnostics Following New Tests and Upgraded Forecasts
Quest Diagnostics has seen its Fair Value Estimate rise moderately from $191.56 to $197.25 per share, reflecting a more optimistic outlook among analysts. This upward revision is largely due to strong ...
In 2022, revenues from Quest Diagnostics’ COVID-19 tests weighed in at nearly half the size of the previous year’s haul—and the testmaker is now expecting 2023’s COVID-related earnings to shrink to an ...
Earlier this week, Quest Diagnostics reported third-quarter earnings exceeding expectations, raised its full-year guidance, and expanded its partnership and acquisition activity to further grow its ...
While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a prior range ...
The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on ...
Quest’s two AD-Detect blood-based tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in ...
Gardner and Wallace will be based in Quest’s Secaucus headquarters, a company representative told NJBIZ. “These latest appointments continue to strengthen Quest’s leadership team and position us well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results